Kaleido Biosciences (KLDO) Competitors $0.0001 0.00 (0.00%) As of 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock KLDO vs. ELYS, PRST, DMN, GROM, KBNT, ALFIW, APCXW, ARBEW, AOGOW, and AOGOUShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Elys BMG Group (ELYS), Presto Automation (PRST), Grafiti (DMN), Grom Social Enterprises (GROM), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), and Arogo Capital Acquisition (AOGOU). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Its Competitors Elys BMG Group Presto Automation Grafiti Grom Social Enterprises Kubient Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Arogo Capital Acquisition Kaleido Biosciences (NASDAQ:KLDO) and Elys BMG Group (NASDAQ:ELYS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk. Which has preferable valuation & earnings, KLDO or ELYS? Elys BMG Group has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.00-$95.48M-$2.240.00Elys BMG Group$43.86M0.00-$18.26MN/AN/A Does the MarketBeat Community prefer KLDO or ELYS? Kaleido Biosciences received 36 more outperform votes than Elys BMG Group when rated by MarketBeat users. However, 75.00% of users gave Elys BMG Group an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformKaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% Elys BMG GroupOutperform Votes1875.00% Underperform Votes625.00% Which has more volatility and risk, KLDO or ELYS? Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Elys BMG Group has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Do insiders & institutionals hold more shares of KLDO or ELYS? 81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 18.5% of Elys BMG Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is KLDO or ELYS more profitable? Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A Elys BMG Group N/A N/A N/A Does the media favor KLDO or ELYS? In the previous week, Elys BMG Group had 2 more articles in the media than Kaleido Biosciences. MarketBeat recorded 2 mentions for Elys BMG Group and 0 mentions for Kaleido Biosciences. Elys BMG Group's average media sentiment score of 0.32 beat Kaleido Biosciences' score of 0.00 indicating that Elys BMG Group is being referred to more favorably in the news media. Company Overall Sentiment Kaleido Biosciences Neutral Elys BMG Group Neutral SummaryElys BMG Group beats Kaleido Biosciences on 7 of the 10 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$125.03M$5.58B$8.50BDividend YieldN/A3.74%5.28%4.17%P/E Ratio0.003.2627.1919.64Price / Sales0.004,109.95408.78152.17Price / CashN/A13.1938.3234.64Price / BookN/A35.896.974.60Net Income-$95.48M-$91.56M$3.23B$248.06M7 Day PerformanceN/A0.88%-0.88%-1.02%1 Month PerformanceN/A6.64%7.81%3.51%1 Year PerformanceN/A173.92%31.53%12.68% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/A$0.00flatN/AN/A$4K$1.10M0.0080Gap DownELYSElys BMG GroupN/A$0.00flatN/A-99.7%$16K$43.86M0.0090News CoverageOptions VolumePRSTPresto AutomationN/A$0.00flatN/A-99.9%$10K$19.05M0.004DMNGrafitiN/A$0.00-77.3%N/AN/A$8K$386.09K0.00N/AGap DownHigh Trading VolumeGROMGrom Social EnterprisesN/A$0.00flatN/A-99.8%$8K$3.72M0.00450KBNTKubientN/AN/AN/A-50.0%$1K$1.17M0.0040Gap UpHigh Trading VolumeALFIWAlfiN/AN/AN/AN/A$0.00$200.68K0.0040APCXWAppTech PaymentsN/A$0.07+24.3%N/A-56.8%$0.00$276K0.0020Positive NewsARBEWArbe RoboticsN/A$0.24-9.2%N/A+17.5%$0.00$671K0.00120News CoveragePositive NewsShort Interest ↓Gap UpAOGOWArogo Capital AcquisitionN/A$0.02flatN/AN/A$0.00N/A0.00N/AAOGOUArogo Capital AcquisitionN/A$8.50flatN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Elys BMG Group Competitors Presto Automation Competitors Grafiti Competitors Grom Social Enterprises Competitors Kubient Competitors Alfi Competitors AppTech Payments Competitors Arbe Robotics Competitors Arogo Capital Acquisition Competitors Arogo Capital Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
